It’s been a long time coming, right? This wait for federal cannabis reform. To show the tides are turning, the MORE Act, which would decriminalize cannabis, advanced one step further in Congress, bringing the US that much closer to a federal decriminalization policy. Can this bill go through?
If the MORE Act does decriminalize cannabis, the USA will be an entirely different place. But even if it doesn’t there’s still a huge selection of cannabis products, like delta-8 THC, and a number of other minor cannabinoids. This is great for everyone, especially users who prefer slightly less high, and less associated anxiety. In fact, we’ve got great deals for delta-8 THC, and many other products, so stop by, and take a look at the options we’ve got for you.
Cannabis in the US of A
Most of us know the basics, but before getting into the changes that are coming, it’s best to go over where we currently stand. Cannabis, in the United States is illegal for both medical and recreational purposes. Cannabis used to be an important aspect of American life, with hemp grown for all kinds of industrial uses, and cannabis being found in tons of medical (and non-medical) products. By the beginning of the 1900’s, the one thing cannabis wasn’t used for as much, was getting high.
Getting into the story of marijuana illegalization is certainly controversial. While some will stick to the government story line of cannabis being dangerous and in need of eradication, the other story involves different factors, like pharmaceutical companies that didn’t want to compete with a plant that could be easily grown by the people themselves, or a paper industry that saw hemp paper as competition, or a chemicals industry that felt likewise about it. When it comes to the illegalization of cannabis, these two stories run counter, but regardless of why it happened, this was the outcome.
In 1937 the Marihuana Tax Act was passed which placed massive taxes and restrictions on marijuana, making it nearly impossible to either research it, without express permission, or use personally. This wasn’t a full illegalization though. Different laws were passed over the years, leading to cannabis being put in Schedule I of the DEA’s Controlled Substances list, with the advent of the 1970 Controlled Substances Act. This made all uses of it illegal, with the plant seen as having no medicinal value, whatsoever.
Federal vs state
Obviously, this isn’t the end of the story, as cannabis is not regulated through the constitution, giving individual states the ability to create their own laws. Not only do many states have decriminalization measures, many stemming from the 70’s when cannabis was first completely illegalized, but the majority have comprehensive medical marijuana programs, and 18 (including two of the most populous states: New York and California), allow legal recreational use, essentially 100% going against the US government.
For those who have been paying attention over the years, this has caused many problems. In the earlier days of medicinal legalizations, the federal government still targeted users, often subjecting them to criminal punishments, though they weren’t breaking state laws. It’s even seen today still. The DEA just announced intentions to expand legal cannabis cultivation in the country, but with caveats that will likely keep former cannabis cultivators who have worked legally by their own state’s laws, from having a chance to participate, since the federal government still considers their past work as criminal activity.
For the most part these attacks have lightened over the years. I expect because there’ve been too many states going against federal regulation for the US to continue attempting to punish people. And with so many states essentially flipping the bird to federal law, it’s also not surprising that the federal government has been scrambling to change directions. This is likely to save face in this changing climate of weed acceptance, where the population has been steadily, and uncompromisingly, going in the opposite direction to federal mandate.
What is the MORE act, and will it decriminalize cannabis?
The first thing to understand about the MORE act (Marijuana Opportunity Reinvestment and Expungement Act), or HR 3617, is that it isn’t a legalization measure at all, but is meant to federally decriminalize cannabis. It would officially de-schedule cannabis out of Schedule I of the Controlled Substances list, and seemingly off of it entirely. This would officially take away criminal penalties for certain crimes. Under the law, individual states could continue to make their own decisions concerning full legalizations in their own domains.
The bill takes a complete 180 degree turn from current policy, essentially saying that cannabis is no longer dangerous, and that it has medical value. In fact, it’s practically a legalization. This is backed up by the fact that the bill would introduce a 5% tax on cannabis products. Usually when the government expects for something not to be sold, it doesn’t attach a tax to it. After all, it means the government fully accepts retail sales if its setting up a system to regulate taxes for it. So though this bill works to decriminalize cannabis, it also clearly promotes its legal sale (and therefore use) by way of setting a taxation amount.
The tax from the products would go to fund projects for criminal and social reform, and would eventually rise to 8% from 5%. Tax money would be distributed by a newly formed agency called the Office of Cannabis Justice, which would reside within the Department of Justice Office of Justice Programs. At least some of the money would be used for grants intended toward communities hard hit by the war on drugs.
Along with this, it would prevent benefits like public housing, or other federal benefits, to be denied to those who have been found guilty of cannabis crimes. It would also keep simple possession or use acts from causing an impact under immigration laws. The new law would do what most legalization bills do, it would expunge past convictions of those who have been found guilty of relevant cannabis crimes. This means, if a person served time for cannabis, or received any kind of relevant conviction, they will no longer have to state this, as it will no longer apply. Those currently under active convictions would be able to petition the courts for a resentencing.
Another aspect of the MORE act is that it would allow marijuana businesses to apply for, and receive, small business administration loans, as well as other banking services and insurance. These are things that have been repeatedly denied to cannabis companies due to federal regulation against the drug.
The MORE act was originally introduced in 2019, and it officially passed the US House of Representatives on December 4th, 2020. This is the first time a part of congress has approved a bill that’s meant to end cannabis prohibition laws. It didn’t have time to go through the Senate though, and therefore had to be reintroduced in 2021. In order to become law, it must pass a final vote in the House – again, as well as make it through a full Senate. The MORE Act has 76 co-sponsors, one of whom is republican.
MORE Act to decriminalize cannabis gets one step further
On September 30th, 2021, the House Judiciary Committee voted on the bill, and passed it by a vote of 26-15. The House Judiciary Committee is chaired by Jerrold Nadler, who is also a co-sponsor of the MORE Act. Though the vote went mainly by party lines with all 26 democrats voting in favor, they were joined by two republicans, while 15 voted no.
As stated before, this bill passed the House in 2020 in a vote of 228-165, but since the Senate never got to it, it couldn’t be passed fully. When a new congress took their seats in January, the whole process actually started from scratch with the reintroduction of the bill. This means that though the same bill was passed in the House already, it will need to repass it again to continue.
The House Judiciary Committee, upon passing the bill, referred the bill for a vote by the entire House once again. As it passed by large margins the last time, it is expected to do okay again, even with a different configuration of congressmen due to the results of the 2020 elections. The much bigger obstacle is for it to get through the Senate. Once it passes the House again, that conversation can begin.
Will the MORE Act to decriminalize cannabis pass?
This is an interesting question, and it can really go either way. It’s not shocking to understand that much of government is still going to be against such a decriminalization, especially those with more conservative mindsets. However, there’s a growing and undeniable reality about all this. Nearly every state has some sort of decriminalization, medical, or recreational policy, even if only a minor one. And the news is constantly filled with mentions of new states pushing through comprehensive medical bills, or full-on recreational ones. About half the country is already living in recreational locations.
The US government weakens itself by allowing this, and since it can’t stop it, or reverse it, or bully it, or arrest it, or even lie about it anymore, it must change tack if it wants to save face. And ultimately, this is non-negotiable. The US can’t have a federal mandate that no state will follow, so the question of ‘will a decriminalization measure or legalization measure go through soon’, has the very easy answer of ‘yes, because it has to.’
Having said that, though the walls are certainly closing in, it could be the next one and not this one. While I expect things can’t go on this way for more than another year tops, it doesn’t mean it has to be this particular bill. I do, however, think the MORE Act has a great chance of passing, even if just because of the timing.
To give an idea of how much the government does understand this, there are now states like North Carolina, where republicans are pushing legalization measures. Not because they agree, but simply because they understand that it’s what their constituents want, and that if they want to keep their seats, this is the new deal.
There is even yet another bill making the rounds in Congress, this one an actual legalization measure. The Cannabis Administration and Opportunity Act is led by Senate Majority Leader Chuck Schumer and seeks to go a step further by legalizing cannabis and instituting a federal market for it. This is more extreme, making the MORE Act slightly more likely between the two, in my estimation. That a bill has to pass soon is a fact of US federal power and control, but chances are it will be a less aggressive one. Competition between the two bills could even cause problems, though they technically do different things, and could potentially both be passed.
This is certainly an exciting time in the world of weed. The MORE Act might just be the ticket to federal cannabis decriminalization, and the end to restrictive and silly prohibition laws. The one thing we can be almost certain of, is that a bill of this nature will pass soon. However, for now, we’ll have to carefully watch progress to see the fate of HR 3617.
Hello to all. Welcome to CBDtesters.co, the best internet location for the most relevant and interesting cannabis and psychedelics-related news from around the world. Read-thru the site regularly to stay on top of the ever-exciting universe of legal drugs and industrial hemp, and sign up to receive our newsletter, so you always know what’s going on.
Disclaimer: Hi, I’m a researcher and writer. I’m not a doctor, lawyer, or businessperson. All information in my articles is sourced and referenced, and all opinions stated are mine. I am not giving anyone advise, and though I am more than happy to discuss topics, should someone have a further question or concern, they should seek guidance from a relevant professional.
Psyched Wellness is Bringing You Amanita Mushrooms – And It’s All Legal
Magic mushrooms are the new buzz word, but they don’t all fall into just one category. Sure, there are psilocybin magic mushrooms, but there are also amanita mushrooms, for a different kind of high and unique medical advantages. Now, the company Psyched Wellness is offering amanita mushroom products, and the best part is, it’s all legal.
We all know about psilocybin mushrooms, right? Well, now there’s a new mushroom to know about, Amanita muscaria, and these mushrooms are not only legal, but come with a host of medical benefits. If you’re into independent drug reporting concerning the cannabis and psychedelics fields, this is the publication for you. We provide the Cannadelics Weekly Newsletter so readers can stay updated on current events, as well as have access to tons of deals on cannabis products including popular cannabinoid compounds Delta 8 THC, and HHC, and all upcoming hallucinogenic products. Check the ‘best of’ lists for offers, and choose the products you’re most comfortable using.
What are amanita mushrooms?
When you hear the term ‘magic mushrooms’ the go-to association is with psilocybin mushrooms, the shrooms readily found in North and South America, which cause trips and highs by activating serotonin receptors. These mushrooms, along with LSD, DMT, and other compounds, are considered psychedelic hallucinogens.
This group of psychedelic hallucinogens doesn’t include other drugs we often think of as psychedelics, like ketamine. That drug, along with PCP and DXM are all dissociative hallucinogens. There is a third group as well, called deliriant hallucinogens, which includes scopolamine, the drug used to rob people by taking away their ability to argue with perpetrators. These three represent serotonergic, dopaminergic, and anticholinergic hallucinogens only.
This is where amanita mushrooms come in, as hallucinogens that act on a different neurotransmitter, GABA. Amanita muscaria mushrooms – AKA fly agaric, (for their ability to attract and trap flies), are also wild mushrooms that produce some trippy effects, but with an entirely different mode of action then psilocybin mushrooms. Amanita mushrooms are considered poisonous mushrooms, and contain a compound called muscimol, which is GABAergic. This means it acts as an agonist on GABA receptors, and does so in the same way as GABA itself; rather than attaching to different receptor sites like benzodiazepines, barbiturates, and Quaaludes.
These mushrooms also contain ibotenic acid, which is the compound more likely to make a person sick. This compound is a prodrug (a compound which is biologically inactive until metabolization), and is metabolized in the body to become muscimol. This is similar to psilocybin, which is also a prodrug, and which is useless in the human body until it changes into the other compound found in magic mushrooms, and the real compound of interest, psilocin.
Whereas psilocin acts on serotonin receptors, creating a stimulant response along with its psychedelic effects, muscimol acts on GABA receptors that calm the body down. Amanita mushrooms therefore won’t cause the same kind of ‘bad trip’ as psilocybin mushrooms, since there’s no stimulant effect. They do, however, come with their own reasons for caution in how they’re prepared and eaten, so as not to make a user feel sick. Neither mushroom group is known to cause death (despite the name ‘poisonous’), so even a bad experience with either is only temporary.
Amanita mushrooms are less well-known in the Americas as they’re not native to this region. For the most part they’re found around Northern Europe and Russia (particularly Siberia), and factor into medicinal and shamanistic traditions in those regions. This is probably why they aren’t scheduled in the US Controlled Substances list, which makes them legal to have and use in the US.
A little about Psyched Wellness & Calm
Psyched Wellness is a publicly traded company on the Canadian Securities Exchange under (CSE:PSYC), which used to be Duncan Park Holdings Corporation. Based out of Toronto, Psyched Wellness is a life sciences company which just finished a pilot run for its new amanita mushrooms product, Calm.
This main offering of the company, Calm, is the first approved amanita mushroom product to hit US markets. According to the company, its made 100% from amanita mushroom caps, is lab tested, detoxified to ensure no bad effects (no ibotenic acid), and can be used to “reduce stress, ease muscular tension, and promote restorative sleep.” The company is taking preorders for the product right now, and interested buyers can reserve themselves a 1 fluid ounce bottle for $49.99. Products are expected to officially hit the market in the fall.
Calm registers as a dietary supplement, which is advertised as ethically sourced. The main component, according to the company’s site, is AME-1 which was developed in the Psyched Wellness laboratories to mimic the naturally extracted compound muscimol. It does not contain naturally occurring muscimol. As this is not a controlled substance, and doesn’t require a prescription, the company is free to sell it without the same complications that currently exist with psilocybin mushrooms, which are still federally illegal as they sit in Schedule I of the controlled substances list.
The company is looking to expand its product offering in the future. According to CEO Jeffrey Stevens, “It has been a long journey to get to this point, and I would like to take this opportunity to thank my co-founder, David Shisel, our team, KGK Science and Vantage Hemp for all of their hard work and commitment to get us to where we are today. The most exciting part for me is that we have just scratched the surface with respect to potential uses and delivery forms for AME-1. Stay tuned for more to come from Psyched.”
Aside from this compound, the company also sells accompanying sweatshirts, bags, T-shirts, phone covers, water bottles, hats, and mugs, some emblazoned with the well-known image of the red capped mushroom with white spots. While Super Mario Brothers certainly kept this image alive for years, its new entrance into the US sales market is sure to give it an extra popularity boost in the near future.
A bit more on muscimol from amanita mushrooms
For many people, these mushrooms represent something completely new. Whereas psilocybin mushrooms have been used in the Americas for millennia, both for medical and recreational purposes, amanita mushrooms are not well-known to this part of the world. They are therefore a mystery to Americans in terms of what they can do, what to be wary of, and how they differ from standard magic mushrooms. In an interview with Technology Networks, Jeff Stevens gave some insight into these ‘other’ hallucinogenic mushrooms.
Of muscimol he says, “Muscimol is one of the main psychoactive compounds found in the Amanita muscaria mushroom along with ibotenic acid and muscarine. Although it does have psychoactive properties, the effect is very different from psilocybin or psilocin. It reacts with the GABAA receptor and when ingested, it can provide feelings of euphoria and tranquility, an altered sense of hearing and taste, changes to sensory perception and vivid dreams.”
He goes on to stipulate that “If it is not processed properly, where the ibotenic acid is not converted to muscimol, it can provide quite a nasty experience including sweating, nausea, loss of balance and involuntary bodily movements.” This helps explain how amanita mushrooms can cause negative effects, but don’t have to so long as the right usage techniques are employed.
In terms of why we’re only hearing about muscimol now, he says, “We believe the reason muscimol has not been studied to a large degree is because it has been mislabeled as poisonous and as such was overlooked. As a result, there’s not been a lot of scientific studies conducted on muscimol so groups like Psyched Wellness need to start from the ground up, making it more time consuming and more expensive.”
When it comes to the legality of the mushrooms, he explains, “Amanita muscaria are considered food and are principally regulated under the Federal Drug Act and the Consumer Packaging and Labelling Act in Canada and the Federal Food, Drug and Cosmetic Act and The Nutrition Labelling and Education Act in the USA. As a result, the challenges that other compounds face with extraction, regulation and or administration are not a factor.”
Psyched Wellness has been going over accumulated research on these mushrooms, looking for different applications. Says Stevens, “we believe muscimol could show positive indications for various mental and physical health issues, including sleep, insomnia, addiction and pain.”
Amanita mushrooms represent a different option in the world of hallucinogenic treatment. It’s not just about standard psychedelics anymore, and amanita mushrooms, with their main psychoactive constituent muscimol, offer an entirely different approach to helping with mental and physical health.
Hello and welcome! Thanks for making it to Cannadelics.com, a top platform for independent coverage of everything in the cannabis and psychedelics worlds. Read-thru the site daily for updates, and subscribe to the Cannadelics Weekly Newsletter, for news items and the best in product offerings.
Double Standards – Will Biden Keep His Cannabis Reform Promises?
Regardless of what side of the political fence you’re on, there is one thing everyone can agree on: Republicans are more conservative, and Democrats are more liberal – especially when it comes to progressive drug policies. And while this statement rings true almost 100% of the time, the exact opposite applies to our current president, Joe Biden.
While Biden has made many cannabis-related promises along the campaign trail and during his time in office, and he has supported a handful of modest reform proposals, the White House has made it very clear that his overall position on adult-use legalization has not changed over the years: he is NOT in favor. And this is despite overwhelming support for progressive policy change among voters in his party.
To stay current on everything important happening in the industry, subscribe to The Cannadelics Weekly Newsletter. Also, it’ll get you premium access to deals on cannabis flowers, vapes, edibles, and much more! We’ve also got standout offers on cannabinoids, like HHC-O, Delta 8, Delta 9 THC, Delta-10 THC, THCO, THCV, THCP & HHC, which won’t kill your bank account. Head over to our “Best-of” lists to get these deals, and remember to enjoy responsibly!
Biden’s daughter-in-law shops for weed with secret service detail
In the most recent Biden-cannabis drama, it was reported last month by the Daily Mail that Melissa Cohen, wife of Hunter Biden and the president’s daughter-in-law, was seen leaving a Malibu-based dispensary called 99 High Tide, and she was carrying a “small unidentified purchase”. Additionally, it was noted that following Cohen was a plain-clothed secret service agent.
Although cannabis is recreationally legal in California and many other states, it’s still federally prohibited… and that’s not exactly where the issue lies anyway. The real problem here, is the idea of using a federally funded secret service to protect one of Biden’s relatives during a pot transaction, while tens of thousands of people remain behind bars for past nonviolent possession charges.
In giving the benefit of the doubt, it’s plausible that Cohen was in the store buying one of their few high-CBD products – which are federally legal. However, while searching through their online menu, I found only one product that fit the bill; the rest of their “CBD products” contained various ratios of THC and CBD, all of which resulted in more than 0.3% THC, and thus, more than the federally legal limit. So, while there is a slight possibility that Cohen was buying CBD products at a recreational cannabis dispensary, it’s highly unlikely.
It’s also worth noting that the Daily Mail’s claim of Cohen having a secret service agent in tow could not be independently verified, as the White House would not respond to questions from the various news sources who have reached out for comments.
White house staffers fired for admitting to past cannabis use
Last spring it was reported through various news outlets that “dozens of young White House staffers, freshly hired were abruptly told to quit, were suspended from their jobs, or otherwise punished “due to past marijuana use.” This happened after the staffers personally admitted to having used cannabis in the past on security clearance application forms. It’s worth noting that cannabis has been legal for adults 21 and older in Washington D.C. since 2015.
The firings and suspensions fly in the face of the more progressive appearance that the White House is trying to present, and their new policies. In February (one month before this incident), the White House Office of Personnel Management stated that past cannabis use was no longer an automatic employment disqualifier, and that federal agencies “should exercise special care before making a determination of unsuitability” in such circumstances.
Whether the staffers’ cannabis use was recreational or medical, legal or illegal, was never made clear. Of the few staffers who commented, under anonymity, the general consensus was that it would not have mattered either way. “The policies were never explained, the threshold for what was excusable and what was inexcusable was never explained,” mentioned one former employee.
The reason why cannabis is considered a “national security risk” or a disqualifier for federal employment, also remains unclear. Both the FBI (Federal Bureau of Investigation) and NSA (National Security Agency) have recently updated their policies on past cannabis use, claiming that it was difficult to find hackers and cybersecurity experts with clean drug records.
Biden’s sketchy history with drug reform
He’s made improvements over the years, but as his documented history shows us, there were very few D.C. lawmakers who were tougher on drugs in the 1980s and 1990s than Senator Joe Biden from Delaware. During the entirety of those 2 decades, Biden was a prominent figure in the War on Drugs and was responsible for unjustly imprisoning tens of thousands of Americans – many of which were minority or low-income individuals – on trumped up drug charges, including thousands for cannabis.
Specifically, Biden introduced numerous bills with that would implement harsh penalties for those convicted of producing and distributing federally prohibited, or schedule 1, narcotics. These bills called for increased severity in dealing with first offenders, as well as longer prison sentences for all. One specific piece of legislature that comes to mind is the 1994 Violent Crime Control and Law Enforcement Act, which sounds good but unfortunately played a key role in mass incarcerations for drug offenses, even many who were not involved in violent crimes.
Biden’s stance never really changed, with him quoted making anti-cannabis comments as recently as 2010. “There’s a difference between sending someone to jail for a few ounces [of marijuana] and legalizing it,” Biden stated in an ABC News Interview. “The punishment should fit the crime. But I think legalization is a mistake. I still believe [marijuana] is a gateway drug.”
However, Biden claims that his views on marijuana have improved lately – but he can say whatever he wants, his actions, however, raise questions. Knowing that Americans want cannabis legalized and available to them, Biden completely changed his tune come January 2019. “There’s a difference between sending someone to jail for a few ounces [of marijuana] and legalizing it. The punishment should fit the crime. But I think legalization is a mistake. I still believe [marijuana] is a gateway drug,” Biden claimed.
A few months later, while speaking with New Hampshire voters in May 2019, Biden commented that, “Nobody should be in jail for smoking marijuana.” He laid out a ‘plan’ for decriminalizing marijuana, if elected, and automatically expunging existing criminal records for possession by reclassifying cannabis to a Schedule II substance (it is currently a Schedule I, reserved for drugs with the highest potential for abuse and addiction).
And in his last 2 years as president, he has acted on exactly zero of his cannabis-related promises. Cannabis is still not federally legal, or even decriminalized, people are still getting in trouble for it in prohibition states, and many are still serving prison time for old cannabis charges in states that have recently legalized. So again, his actions show much less support than he likes to claim.
In one of his latest moves, he suggested forced rehabilitation for anyone caught with drugs. According to President Biden, “nobody convicted of a drug crime should go to prison, they should go to mandatory rehabilitation,” he emphasized at a campaign event in Kenosha, Wisconsin late last year. “Instead of building more prisons… we [should] build rehabilitation centers.” And while I completely agree with the first half of the statement, the idea of putting a cannabis user in rehab, just sounds completely asinine. Although it seems that he’s trying (a little bit), at best, he’s just very out of touch with what modern day drug policy should look like, and what his voters are asking for.
And Vice President Kamala Harris is not much better, claiming to support legalization and even bragging about having smoked in the past, but her resume says otherwise. During her career as San Francisco district attorney, Harris oversaw roughly 1,900 marijuana convictions (1,500 of which were African American males, for the record). NORML executive director Erik Altieri describes her history on drug reform has been “problematic,” and her “record is not one anyone would qualify as progressive, particularly when it comes to marijuana.”
Biden pardons a few cannabis offenders
And when I say “a few”, I truly mean that. More specifically, he pardoned 3 people and commuted the sentences of 78 offenders, out of the estimated 40,000 people who remain locked up on weed charges. Before getting further into the details, let’s quickly go over the difference between pardons and commuted sentences A pardon completely removes the conviction as if it never happened, so the person’s record is clear, whereas a commuted sentence still stands but the punishment is reduced or completely revoked.
The news of the pardons and commuted sentences were announced on Tuesday, April 25th of this year. All of the pardoned offenders had been previously released to serve time in their homes during the pandemic, a privilege that was granted to a total of 8.300 inmates because of COVID-related issues and prison overcrowding. One of the pardons given, and eight of the commuted sentences, were related to cannabis.
Now, it’s important to note that this was not part of some cannabis-related project or anything special that Biden was doing. These pardons and commuted sentences were done in clemency grants as part of Biden’s first year in office – and this is standard for ALL presidents during their first year. Call it a presidential ‘get out of jail free’ card, if you will, but regardless, it had nothing to do with commuting the sentences of cannabis users specifically, even though some of the offenders who got pardoned and commuted were convicted of non-violent marijuana crimes.
New cannabis legalization bill from Chuck Schumer
The reason this matters (well, it always matters, but the reason it’s more relevant now) is because a new decriminalization bill was introduced by Democratic Senate Majority Leader Chuck Schumer and Thursday, July 21st. The bill isn’t exactly new, Schumer has been working on it for years, waiting for the right time to make it official.
The Cannabis Administration and Opportunity Act would effectively decriminalize cannabis at the federal level, but would allow individual states to regulate it as they see fit. So, some states can still choose to keep it illegal, although that seems unlikely. That said, it’s hard to say how likely it is that this bill will even pass at all. Yes, Schumer circulated the bill around for the last few months getting feedback for how to make it foolproof, but there are still a few major potential obstacles in the way.
First, we have the Senate. Although legalization/decriminalization bills have passed the House of Representatives, they have all died when reaching the Senate for a vote. Beyond the Senate, the main concern here is Biden. Should the bill make it his desk, will he off on it? He claims to support decriminalization (hopefully more so now that we all know his daughter-in-law shops at dispensaries), but his history, as well as his areas of focus while in office, say otherwise.
In all fairness, it’s not surprising to see an old man stuck in such dated ways. It’s reminiscent of many of our own grandparents who just won’t get with the times. But a politician should be more in touch with what the general population wants, and data from Politico consistently shows that roughly 70% of Americans want cannabis legalized. With this new bill in the works, it’s very possible that the ball will soon be in Biden’s court – and it will be interesting to see what he does with it.
Welcome all! Thanks for dropping by Cannadelics.com, a top offering for comprehensive news covering the burgeoning cannabis and psychedelics industries. Stop by daily for a dose of news on these dynamically changing fields, and sign up for The Cannadelics Weekly Newsletter, so you’re up on everything important going on.
Switzerland Implements Wide-Reaching Medical Cannabis Program
All eyes are on Switzerland as the country makes big moves to start its own cannabis industry. The country announced plans for a recreational measure last year, and now Switzerland is introducing a wide-reaching medical program that goes far beyond its previous limits.
Switzerland is on a rampage, both widening its medical cannabis program, and awaiting new recreational legislation. Cannadelics is an independent news source focusing on the cannabis and psychedelics fields of today. Remember to subscribe to The Cannadelics Weekly Newsletter all the latest news and industry stories, as well as exclusive deals on flowers, vapes, edibles, and other products. Also save big on Delta 8, Delta 9 THC, Delta-10 THC, THCO, THCV, THCP & HHC products by checking out our “Best-of” lists!
Switzerland up until now
Switzerland is all over the board these days, but up until recently, this was not the case. So what was the deal with Switzerland up until its impressive moves of late? First off, Switzerland is not a part of the EU, so it never had to go by EU regulation. Whereas products with up to .3% THC are legal in EU countries, Switzerland has a max THC level of 1%. Outside of this, cannabis is illegal.
In 2012, the country instituted a decriminalization measure which allowed for small amounts of cannabis (up to 10 grams) with only a 100 Swiss Franc fine, and no jail time included. Once either the 10-gram limit is gone over, or the 1% THC limit, a violator is subject to both a fine, and a prison sentence up to three years.
A lot happened in 2012, though it didn’t all stick. That year, certain cities gained the ability to legally grow low-THC hemp, up to the 1% limit. But then, Just months after this started, the government itself nullified this ability, because it said it was in violation of federal drug laws. Switzerland operates like many multi-state countries where cannabis penalties vary between its different states.
In another 2012 measure, legislation was instituted that made both selling cannabis, as well as possessing amounts enough to affect as many as three people, punishable by up to three years in jail, along with a possible fine. This was updated in 2017 to exclude possession, and to only fine those actively using; which allowed many states to drop possession cases for small amounts.
In terms of Switzerland and a medical cannabis program, the country didn’t have a comprehensive one until current events. The Federal Act on Narcotics and Psychotropic Substances in 2008 (implemented in 2011) allows Swiss doctors to get special permits to prescribe cannabis to terminal patients, for 12 months at a time. It also requires patients to apply for authorization from the FOPH (Federal Office of Public Health). Only tinctures and oils were approved by this measure, and its hardly wide-ranging, with only two pharmacies able to provide such medications.
This didn’t stop the pharma medicine Epidiolex from gaining approval in 2018, even as flowers and resin are both barred. From this time, however, pharmacies have been able to create specific CBD formulations for patients. Overall, the ability to access cannabis medicines has been highly restricted in Switzerland, though recent changes are now opening the country to much wider usage, with even bigger plans for the future.
Switzerland updates medical program
Everything just mentioned about Switzerland and its medical program, has now been updated thanks to a new amendment put forth by the country’s seven-member Federal Council, which is the country’s joint head of state and federal government. This amendment updates the Narcotics Act to erase the ban on medical cannabis, which in turn creates a much wider market.
Starting in the beginning of August, patients no longer have to apply for the authorization from the FOPH, and can now get a regular prescription, straight from their doctor. The new amendment isn’t just meant for patients in Switzerland, but predictably for an export market as well (very few legalizations of this sort don’t include the ability for an export market). Less was stated about an impending import market. The limit for THC is still the same for all products, at 1%.
Part of the reason for this change, was due to increasing demand for medical authorizations, which had grown to the point of burdening the government with extra administrative work, which led to treatment delays for patients in need. The conditions for treatment also expand under this new amendment, letting more people benefit from cannabis medication.
According to the government, this update should be beneficial to those suffering from spastic diseases, and pain issues. Prior to the update, approximately 3,000 approvals for medical cannabis were given yearly to those suffering from the likes of neurological diseases, MS, and cancer.
In order for the amendment to take effect, it required changes to the Narcotics Control Ordinance and the Narcotics List Ordinance. Cultivation regulation for this new medical industry falls under the Swiss Agency for Therapeutic Products (Swissmedic).
Nothing was updated concerning reimbursement for cannabis medications by the healthcare system of the country. As medical cannabis is only reimbursed in the most dire of cases, this indicates that many people will be paying out of pocket for their cannabis medicine, even when legally prescribed by a doctor. The reason given for this omission is that there isn’t enough available evidence on cannabis as an effective treatment, which makes very little sense since it was considered effective enough to be legalized for this purpose.
What about a full recreational legalization?
Switzerland looks like it will be the first country in Europe to set up a regulated sales market, along with trials meant to help establish new regulation. In 2020 I reported about the Swiss government green-lighting trials for recreational cannabis, a project that has been in the works for many years. The trials will allow the legal production and sale of cannabis, but only in specific locations and with many restrictions. In September of 2020, the Federal Act on Narcotics and Psychotropic Substances was officially amended by way of parliamentary approval, which allows scientific trials for selected groups. This went into effect May, 2021.
These regulations set maximum THC limits to 20%, come with limits for pesticide residue, and also mandate warning labels. In order to be a part of these trials, and have access to this recreational cannabis, individual cities and municipalities must first prove that recreational cannabis is not hurting their current population.
As of April 2022, the first of these recreational test programs was authorized specifically for Basel, Switzerland. This specific program is meant to last two years, includes 400 adults, and essentially is meant to provide data for future pricing and consumption regulation, for a full recreational market.
Though the pilot studies sound interesting, they’re really only to help with what’s coming. Even before the programs officially started, a parliamentary commission made a vote in October 2021, which ruled that cannabis shouldn’t be banned, and that the country must establish legislation to officially legalize it. In essence, Switzerland has legalized recreational cannabis, and is simply waiting for a bill (the vote doesn’t change anything without written legislation).
The whole thing is a little confusing. Switzerland is pushing for scientific trials to assess how to run a recreational market, while already working on the legislation to set up that market. And to make it more confusing, the basics of this began before Switzerland even implanted a full medical system, which is only happening now. Somehow none of this seems like its in the right order, but one thing for sure is, progress is great, no matter how it comes. And Switzerland is sure in the fast lane to major cannabis reform.
Perhaps competition with Germany is part of what’s spurring this on so quickly. The neighboring countries are both planning for recreational legalizations, and are both getting amped up to enter the global market. Switzerland for its part is working on both ends. Updating its medical program, before instituting its recreational one.
Welcome all! We appreciate you joining us at Cannadelics.com, a top internet news source for independent coverage of the new and growing cannabis and psychedelics landscapes. Read-thru the site daily for industry updates of all kinds, and check out the Cannadelics Weekly Newsletter, so you always know what’s going down.
- smoking1 year ago
A look inside Jim Belushi's 93-acre cannabis farm in Southern Oregon
- benefits of thcv1 year ago
BREAKING: MASSIVE FOOD SHORTAGE ACROSS THE USA – GOVERNMENT WARNING ON CROP LOSS AND WATER SHORTAGE
- Cannabinoids12 months ago
Legal Loophole? Everyone is Buying Legal Delta 9 THC Gummies Online…
- Deals11 months ago
Have You Tried The New High-Potency THCP Vape Cartridges?
- CBD11 months ago
North Carolina Medical Marijuana Legalization Bill Approved by Senators in Committee
- food1 year ago
Cannabis Infused MCT Oil Tincture FOR HIGH THC EDIBLES
- Cannabinoids1 year ago
What Is HHC (Hexahydrocannabinol) and Is It Safe To Use?
- CBD1 year ago
Federal Cannabis Legalization Will Happen Before 2022, According to Rohrabacher
- Education1 year ago
6 milestones in the CBD industry
- smoking12 months ago
THESE CARDANO PROJECTS WILL 100X IN 2021 🚀 (Get In ASAP)